explore -WSS

explore

author：comprehensive 2025-08-23 08:52:58 - browse：4

The Novartis booth at ESMO in Madrid. — The Novartis booth at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Results presented Monday could expand the use of a Novartis therapy for metastatic prostate cancer, moving it from a treatment used after chemotherapy to one with demonstrated benefits beforehand as well.

The Phase 3 data, highlighted in a prime session here at the annual meeting of the European Society for Medical Oncology, also amount to another win for cancer therapies designed to deliver radiation directly to tumor cells. It’s a field that Novartis has poured investments into, and that is attracting interest from other pharma companies.

The trial, called PSMAfore, enrolled patients with a type of metastatic prostate cancer whose disease had started to progress after taking a drug known as an androgen receptor pathway inhibitor, or ARPI. Patients were randomized to either receive a different ARPI or Novartis’ therapy, Pluvicto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： New chief aims to remake Sanofi Genzyme

focus

entertainment

WSS

Montana youths win climate lawsuit against state for promoting fossil fuels

Treatments for cramps don't cut it. Why aren't there better options?

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Florida babysitter arrested over hot car death, authorities say

Timeline: How the deadly wildfires took over Maui day by day

hotspot

explore

leisure time

Medicare details structure of new drug price negotiation program

Dozens dead from Maui wildfires: What we know about the victims

Moonlake's readout produced a cash windfall. Risks remain

It's time to take a new tack for treating Alzheimer's

Guidelines to prevent youth baseball injuries need more muscle

How Brent Saunders' Allergan experiment failed

Malaria cases in Florida and Texas: Here’s what you need to know

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

What does generative AI mean for health care? We asked experts

Hospitals are dialing back on venture capital investing

hotspot

Health AI: on the border between health care and tech

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Maui wildfire now ranks as the fifth

Senators push IRS to launch nonprofit hospital probe

Timeline: How the deadly wildfires took over Maui day by day

Hospitals are dialing back on venture capital investing

focus

focus

entertainment

focus